Hospice

Hospira was a leading global provider of injectable drugs and infusion technologies, and a pioneer in the development of biosimilars. The company specialized in generic injectable pharmaceuticals, medication management systems, and various infusion therapy products. Following its spin-off from Abbott Laboratories in 2004, Hospira established itself as a major player in the hospital products market. In 2015, the company was acquired by Pfizer for approximately $17 billion, significantly expanding Pfizer's established medicines and sterile injectables portfolio. Today, its operations are integrated into Pfizer's global supply chain and product offerings.